A Novel Approach to mRNA Isolation using PNAs

Information

  • Research Project
  • 6338174
  • ApplicationId
    6338174
  • Core Project Number
    R43CA088703
  • Full Project Number
    1R43CA088703-01A1
  • Serial Number
    88703
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/1/2001 - 23 years ago
  • Project End Date
    3/31/2002 - 22 years ago
  • Program Officer Name
    COUCH, JENNIFER A
  • Budget Start Date
    4/1/2001 - 23 years ago
  • Budget End Date
    3/31/2002 - 22 years ago
  • Fiscal Year
    2001
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    3/28/2001 - 23 years ago
Organizations

A Novel Approach to mRNA Isolation using PNAs

DESCRIPTION (Applicant's abstract): Peptide nucleic acids (PNAs) have a number of features that suggest they would be ideal probes for purifying mRNA. In this revised format we have demonstrated the use of phosphono PNAs (pPNAs) in an RNA isolation procedure that improves the recovery of RNAs with secondary structure at the poly A region and RNAs with short poly A tails. We have developed a procedure for isolating mRNA (free of genomic DNA) from cells and tissue using pPNAs, and provided this kit to the research community. The goal of this revised Phase I study is to further develop the pPNA technology as to enable isolation of mRNA in a high-throughput format. Also by incorporating a novel PNA-like monomer on the base of trans-4-hyroxy-L-proline (HypNA) into the pPNA backbone we hope to be able to purify mRNA from plant Total RNA. This development of PNA technology would enable the HypNA-pPNA chimera to hybridize with plant mRNA molecules regardless of the presence of plant polyphenolics. In Phase II of this study, we would hope to further develop this technology such that it can be used in a novel approach to mRNA isolation from bacterial cells as well as to develop HypNA-pPNAs chimeras for array technology. PROPOSED COMMERCIAL APPLICATION: Any group that is trying to obtain a complete set of transcripts may find an application for pPNA technology. This may include those working on the Mammalian Gene Collection (MGC). We already supply the first two versions of the kit, Maxi and Midi mVADER, to the research community. Any future products generated from this proposal will also be provided to the research community. With the 96-well format this kit will allow high throughput analysis of gene expression for drug screening and functional genomics-applications. This kit would also facilitate those interested in generating mRNA for array profiles or for those interested in studying quantitative RT-PCR. We believe that the invading properties of pPNAs will enable capture of plant mRNA molecules even in the presence of lipopolysaccharides and polyphenolics. The successful application of pPNA technology to plant biotechnology would certainly increase the market potential of this product.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    93197
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
    NCI:93197\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ACTIVE MOTIF, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    CARLSBAD
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    92008
  • Organization District
    UNITED STATES